Persistent Dizziness and Nausea in Patients Receiving Postoperative Epidural Pain Control After Living Donor Liver Transplantation: Case Reports

2008 ◽  
Vol 40 (8) ◽  
pp. 2484-2485 ◽  
Author(s):  
Y.C. Liu ◽  
K.S. Poon ◽  
R.S.C. Wu ◽  
C.C. Lee ◽  
L.B. Jeng
2017 ◽  
Vol 45 (6) ◽  
pp. 2146-2152 ◽  
Author(s):  
Guoyong Chen ◽  
Janjun Sun ◽  
Sidong Wei ◽  
Yongfeng Chen ◽  
Gaofeng Tang ◽  
...  

ABO-incompatible (ABO-i) living-donor liver transplantation (LDLT) is performed if an ABO-compatible graft cannot be obtained. However, a perfect desensitization protocol has not been established worldwide, especially for simultaneous ABO-i LDLT and splenectomy. We herein report two cases of ABO-i LDLT. To the best of our knowledge, this is the first case report of ABO-i LDLT in an adult patient in China. Splenectomy and T-cell-targeted immunosuppression (basiliximab) was used to overcome the blood group barrier in these recipients. The patients had good graft function without signs of antibody-mediated rejection throughout the 12-month follow-up. Thus, ABO-i LDLT with splenectomy is undoubtedly life-saving when an ABO-compatible graft cannot be obtained for patients in critical condition.


2005 ◽  
Vol 40 (3) ◽  
pp. E35-E37 ◽  
Author(s):  
Hideya Kamei ◽  
Mureo Kasahara ◽  
Kenji Uryuhara ◽  
Koichi Kozaki ◽  
Kohei Ogawa ◽  
...  

Swiss Surgery ◽  
2003 ◽  
Vol 9 (5) ◽  
pp. 227-236 ◽  
Author(s):  
Majno ◽  
Mentha ◽  
Berney ◽  
Bühler ◽  
Giostra ◽  
...  

Living donor liver transplantation is a relatively new procedure in which the right side of the liver is harvested in a healthy donor and transplanted into a recipient. After the first case in 1994, over 3000 cases have been done worldwide. This review summarizes the reasons why the procedure is needed, describes its main technical aspects, highlights the boundaries in which it can be done safely, summarizes the current experience worldwide and describes the main points of the program in our unit. We argue that living-donor transplantation is a viable alternative to a long time on the waiting list for several patients, and it can be performed safely and successfully provided that all precautions are undertaken to minimize the risks in the donor and to increase the chances of a good outcome in the recipients. If these prerequisites are met, and within the framework of a structured multidisciplinary program, we believe that living-donor liver transplantation should be funded by health insurances as a recognized therapeutic option.


Sign in / Sign up

Export Citation Format

Share Document